{
  "docId": "019de076-b3a4-71cc-8183-985590ab9557",
  "docSlug": "2fc842fd1dad3dbfa44767764fb3543f",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 21 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 21,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": "The slide uses a three-column layout to summarize technology, market leadership, and business model.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b3a4-71cc-8183-985590ab9557/3",
  "deckHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557",
  "deckJsonHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557.json",
  "deckAnchorHref": "/decks/019de076-b3a4-71cc-8183-985590ab9557#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.16,
        "x": 0.808,
        "y": 0.045
      },
      "kind": "image",
      "text": "MaxCyte",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2932c290-68f6-4858-a32a-15699fff8127",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "list",
      "text": "With 600+ platforms in place, our proprietary technology unlocks the significant potential of advanced therapeutics",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b9f52c9-2823-4e5b-9b0b-b3a56b53650e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.67,
        "y": 0.2
      },
      "kind": "list",
      "text": "Innovative business model focused on value creation and shared partnership success",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8825ae0e-b506-4d1b-803b-3a5476a1ec4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.03,
        "y": 0.45
      },
      "kind": "list",
      "text": "Enables delivery of almost any molecule into almost any cell type; Leads the industry in performance; Extensive product portfolio; ~25% 5-Year CAGR; ~89% gross margins",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "970423ba-3153-4128-a8c3-7f8ce6063a89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.35,
        "y": 0.2
      },
      "kind": "list",
      "text": "Leading the growing next-generation cell therapy market and capitalizing on rising demand for non-viral engineering approaches",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b1ba298-0fd9-4bc5-a55e-5a0ba2ac0c50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.35,
        "y": 0.45
      },
      "kind": "list",
      "text": "20+ years of expertise; 30+ field sales; Significant collaborations; FDA Master File; Used in 45+ clinical trials",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3384363-a153-4a2a-964f-76ee26ec5266",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.67,
        "y": 0.45
      },
      "kind": "list",
      "text": "Allows MaxCyte to participate in value created; 24 SPL partnerships; ~$2B in potential milestone payments; Focused on long-term diverse portfolio",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e2e6d9f9-eb67-4336-9f5a-18af803ad705",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.67,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*As of December 31, 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b8fed0e-34dd-46a5-80c3-8065facddafb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "A Leading Provider of Cell-Engineering Platform Technologies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88efcee9-8639-4d55-89ef-9323c33f88ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "bd25519d-cab6-4539-a532-edc9758648d7",
      "evidence": "Enables delivery of almost any molecule into almost any cell type; Leads the industry in performance; Extensive product portfolio; ~25% 5-Year CAGR; ~89% gross margins",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}